Harmon Seth 4
4 · Viridian Therapeutics, Inc.\DE · Filed Nov 13, 2023
Insider Transaction Report
Form 4
Harmon Seth
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-11-10+270,000→ 270,000 totalExercise: $13.76Exp: 2033-11-10→ Common Stock (270,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments through November 10, 2027, subject to the Reporting Person's continued service to Issuer through each vesting date.